# House of Doge Inc.: financial statements, quarterly

HODO · Nasdaq · CIK 1903595 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hodo.md) · [Financials](/companies/hodo/financials.md) · [Filings](/companies/hodo/filings.md) · [Insiders](/companies/hodo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hodo/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001213900-25-065688.md) | [0.0 d](/filings/0001213900-25-077589.md) | [0.0 d](/filings/0001213900-25-111616.md) | [0.0 d](/filings/0001213900-26-046293.md) | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-26-090312.md) |
| Cost of revenue | $m | [0.0](/filings/0001213900-25-065688.md) | [0.0 d](/filings/0001213900-25-077589.md) | [0.0 d](/filings/0001213900-25-111616.md) | [0.0 d](/filings/0001213900-26-046293.md) | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-26-090312.md) |
| Gross profit | $m | [(0.0)](/filings/0001213900-25-065688.md) | [0.0 d](/filings/0001213900-25-077589.md) | [0.0 d](/filings/0001213900-25-111616.md) | [0.0 d](/filings/0001213900-26-046293.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [0.0](/filings/0001213900-25-065688.md) | [0.0](/filings/0001213900-25-077589.md) | [0.0](/filings/0001213900-25-111616.md) | [0.0 d](/filings/0001213900-26-046293.md) | [0.0](/filings/0001213900-26-057818.md) | [0.0](/filings/0001213900-25-077589.md) | [0.0](/filings/0001213900-25-111616.md) | [0.0 d](/filings/0001213900-26-046293.md) | [0.1](/filings/0001213900-26-057818.md) | not reported |
| Selling, general and administrative | $m | [0.1](/filings/0001213900-25-065688.md) | [0.2](/filings/0001213900-25-077589.md) | [0.1](/filings/0001213900-25-111616.md) | [0.2 d](/filings/0001213900-26-046293.md) | [0.3](/filings/0001213900-26-057818.md) | [0.6](/filings/0001213900-25-077589.md) | [0.7](/filings/0001213900-25-111616.md) | [1.7 d](/filings/0001213900-26-046293.md) | [0.7](/filings/0001213900-26-057818.md) | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | [(11.8)](/filings/0001213900-26-090312.md) | not reported | not reported | not reported | [4.4](/filings/0001213900-26-090312.md) |
| Interest expense | $m | [0.8](/filings/0001213900-25-065688.md) | [0.5](/filings/0001213900-25-077589.md) | [0.7](/filings/0001213900-25-111616.md) | [0.2 d](/filings/0001213900-26-046293.md) | [0.4](/filings/0001213900-26-057818.md) | [0.0 d](/filings/0001213900-25-077589.md) | [0.0 d](/filings/0001213900-25-111616.md) | [1.0 d](/filings/0001213900-26-046293.md) | [0.2](/filings/0001213900-26-057818.md) | not reported |
| Income tax | $m | not reported | [0.1](/filings/0001213900-25-077589.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(1.0)](/filings/0001213900-25-111616.md) | [(1.0)](/filings/0001213900-25-111616.md) | [(1.0)](/filings/0001213900-25-111616.md) | [(0.3) d](/filings/0001213900-26-046293.md) | [(1.1)](/filings/0001213900-26-057818.md) | [(12.1)](/filings/0001213900-26-090312.md) | [2.5](/filings/0001213900-25-111616.md) | [(15.7) d](/filings/0001213900-26-046293.md) | [(1.5)](/filings/0001213900-26-057818.md) | [4.0](/filings/0001213900-26-090312.md) |
| Diluted EPS | $ per share | [(0.18)](/filings/0001213900-25-065688.md) | [(0.17)](/filings/0001213900-25-077589.md) | [(0.18)](/filings/0001213900-25-111616.md) | not reported | [(0.14)](/filings/0001213900-26-057818.md) | [(0.24)](/filings/0001213900-26-090312.md) | [0.10](/filings/0001213900-25-111616.md) | not reported | [(0.07)](/filings/0001213900-26-057818.md) | [0.05](/filings/0001213900-26-090312.md) |
| Basic EPS | $ per share | [(0.18)](/filings/0001213900-25-065688.md) | [(0.17)](/filings/0001213900-25-077589.md) | [(0.18)](/filings/0001213900-25-111616.md) | not reported | [(0.14)](/filings/0001213900-26-057818.md) | [(0.24)](/filings/0001213900-26-090312.md) | [0.23](/filings/0001213900-25-111616.md) | not reported | [(0.07)](/filings/0001213900-26-057818.md) | [0.05](/filings/0001213900-26-090312.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.0](/filings/0001213900-25-040732.md) | not reported | not reported | not reported | [0.0](/filings/0001213900-25-040732.md) | [3.2](/filings/0001213900-25-065688.md) | [1.5](/filings/0001213900-25-077589.md) | [9.6](/filings/0001213900-25-111616.md) | not reported | [2.8](/filings/0001213900-26-090312.md) | [0.7](/filings/0001213900-26-090312.md) |
| Current assets | $m | not reported | [0.1](/filings/0001213900-25-040732.md) | not reported | not reported | not reported | [0.1](/filings/0001213900-26-046293.md) | [3.5](/filings/0001213900-25-065688.md) | [1.9](/filings/0001213900-25-077589.md) | [9.7](/filings/0001213900-25-111616.md) | [12.7](/filings/0001213900-26-057818.md) | [7.1](/filings/0001213900-26-090312.md) | [3.5](/filings/0001213900-26-090312.md) |
| Total assets | $m | not reported | [0.7](/filings/0001213900-25-040732.md) | not reported | not reported | not reported | [1.3](/filings/0001213900-26-046293.md) | [3.7](/filings/0001213900-25-065688.md) | [2.3](/filings/0001213900-25-077589.md) | [18.2](/filings/0001213900-25-111616.md) | [14.8](/filings/0001213900-26-057818.md) | [21.8](/filings/0001213900-26-090312.md) | [32.5](/filings/0001213900-26-090312.md) |
| Current liabilities | $m | not reported | [6.8](/filings/0001213900-25-040732.md) | not reported | not reported | not reported | [9.8](/filings/0001213900-26-046293.md) | [2.1](/filings/0001213900-25-065688.md) | [1.4](/filings/0001213900-25-077589.md) | [1.6](/filings/0001213900-25-111616.md) | [7.4](/filings/0001213900-26-057818.md) | [14.3](/filings/0001213900-26-090312.md) | [19.9](/filings/0001213900-26-090312.md) |
| Total liabilities | $m | not reported | [6.8](/filings/0001213900-25-040732.md) | not reported | not reported | not reported | [9.8](/filings/0001213900-26-046293.md) | [2.1](/filings/0001213900-25-065688.md) | [1.4](/filings/0001213900-25-077589.md) | [1.6](/filings/0001213900-25-111616.md) | [11.4](/filings/0001213900-26-057818.md) | [18.7](/filings/0001213900-26-090312.md) | [23.9](/filings/0001213900-26-090312.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [8.6](/filings/0001213900-26-090312.md) | [23.2](/filings/0001213900-26-090312.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-25-040732.md) | not reported | not reported | not reported | not reported | [9.3](/filings/0001213900-26-090312.md) | [5.1](/filings/0001213900-26-090312.md) |
| Shareholders' equity | $m | [(2.0)](/filings/0001213900-25-040732.md) | [(6.1)](/filings/0001213900-26-046293.md) | [(7.1)](/filings/0001213900-25-111616.md) | [(7.5)](/filings/0001213900-25-111616.md) | [(8.2)](/filings/0001213900-25-111616.md) | [(8.5)](/filings/0001213900-26-057818.md) | [8.4](/filings/0001213900-26-090312.md) | [16.4](/filings/0001213900-26-090312.md) | [16.6](/filings/0001213900-25-111616.md) | [3.4](/filings/0001213900-26-057818.md) | [3.1](/filings/0001213900-26-090312.md) | [8.6](/filings/0001213900-26-090312.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [56.3](/filings/0001213900-25-065688.md) | [(241) d](/filings/0001213900-25-077589.md) | [(344) d](/filings/0001213900-25-111616.md) | [(41.5) d](/filings/0001213900-26-046293.md) | [(1,767)](/filings/0001213900-26-057818.md) | [(4,010)](/filings/0001213900-26-090312.md) | [(989) d](/filings/0001213900-25-111616.md) | [(2,409) d](/filings/0001213900-26-046293.md) | [(842)](/filings/0001213900-26-057818.md) | [(1,581)](/filings/0001213900-26-090312.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [7.3](/filings/0001213900-26-090312.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.6](/filings/0001213900-25-065688.md) | [5.6](/filings/0001213900-25-077589.md) | [5.7](/filings/0001213900-25-111616.md) | [7.7](/filings/0001213900-26-057818.md) | [50.4](/filings/0001213900-26-090312.md) | [26.1](/filings/0001213900-25-111616.md) | [21.9](/filings/0001213900-26-057818.md) | [79.6](/filings/0001213900-26-090312.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 84,902,985 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-090312.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.